New product introduction at TyRx Pharma, Inc.

Abstract

Purpose – To describe a practice that has implications for new product introduction within and outside the medical products industry. Design/methodology/approach – The case describes a systems approach to new product introduction that includes a number of non‐marketing factors. The organization's original name has been retained. One of the authors is an executive with the company and used both internal and publicly available data to write the case study. Findings – The case provides information and a solid action approach to new product launch. The subject company designed a comprehensive launch strategy that involved new product modification as well as selection of appropriate price and distribution strategies. The results offer direct implications for new product development teams in the drug and medical implements industries. Research limitations/implications – As in all case studies, the specific conditions found in one organization may not be found more generally in others. Readers are cautioned that the conclusions drawn in the case may have limited applicability. Practical implications – The case depicts a professional implementation of a new product launch. Other organizations may find the technique of value in their own efforts. Originality/value – The case is a unique implementation of a new product launch strategy that has a comprehensive foundation. It offers lessons that may be applied to other companies faced with similarly competitive, regulatory and technological environments.